Proteomics analysis of lung tissue reveals protein makers for the lung injury of adjuvant arthritis rats
- Authors:
- Ping-Heng Zhang
- Dan-Bin Wu
- Jian Liu
- Jian-Ting Wen
- En-Sheng Chen
- Chang-Hong Xiao
-
Affiliations: Rheumatology and Immunology Department, Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, Guangzhou, Guangdong 510315, P.R. China, Department of Traditional Chinese Medicine, School of Medicine, First Affiliated Hospital, Zhejiang University, Hangzhou, Zhejiang 310003, P.R. China, Department of Rheumatology and Immunology, First Affiliated Hospital of Anhui University of Traditional Chinese Medicine, Hefei, Anhui 230038, P.R. China - Published online on: July 11, 2023 https://doi.org/10.3892/mmr.2023.13051
- Article Number: 163
-
Copyright: © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
 |
 |
 |
 |
 |
 |
 |
|
Prasad P, Verma S, Surbhi, Ganguly NK, Chaturvedi V and Mittal SA: Rheumatoid arthritis: Advances in treatment strategies. Mol Cell Biochem. 478:69–88. 2023. View Article : Google Scholar : PubMed/NCBI | |
|
Kan S, Duan M, Liu Y, Wang C and Xie J: Role of mitochondria in physiology of chondrocytes and diseases of osteoarthritis and rheumatoid arthritis. Cartilage. 13 (2 Suppl):1102S–1121S. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Zhou S and Huang G: Some important inhibitors and mechanisms of rheumatoid arthritis. Chem Biol Drug Des. 99:930–943. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Minichiello E, Semerano L and Boissier MC: Time trends in the incidence, prevalence, and severity of rheumatoid arthritis: A systematic literature review. Joint Bone Spine. 83:625–630. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Akiyama M and Kaneko Y: Pathogenesis, clinical features, and treatment strategy for rheumatoid arthritis-associated interstitial lung disease. Autoimmun Rev. 21:1030562022. View Article : Google Scholar : PubMed/NCBI | |
|
Kelly C, Emery P and Dieudé P: Current issues in rheumatoid arthritis-associated interstitial lung disease. Lancet Rheumatol. 3:e798–e807. 2021. View Article : Google Scholar | |
|
Conforti A, Di Cola I, Pavlych V, Ruscitti P, Berardicurti O, Ursini F, Giacomelli R and Cipriani P: Beyond the joints, the extra-articular manifestations in rheumatoid arthritis. Autoimmun Rev. 20:1027352021. View Article : Google Scholar : PubMed/NCBI | |
|
Akira M, Sakatani M and Hara H: Thin-section CT findings in rheumatoid arthritis-associated lung disease: CT patterns and their courses. J Comput Assist Tomogr. 23:941–948. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Koduri G, Norton S, Young A, Cox N, Davies P, Devlin J, Dixey J, Gough A, Prouse P, Winfield J, et al: Interstitial lung disease has a poor prognosis in rheumatoid arthritis: Results from an inception cohort. Rheumatology (Oxford). 49:1483–1489. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Lee HK, Kim DS, Yoo B, Seo JB, Rho JY, Colby TV and Kitaichi M: Histopathologic pattern and clinical features of rheumatoid arthritis-associated interstitial lung disease. Chest. 127:2019–2027. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Zamora-Legoff JA, Krause ML, Crowson CS, Ryu JH and Matteson EL: Progressive decline of lung function in rheumatoid arthritis-associated interstitial lung disease. Arthritis Rheumatol. 69:542–549. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Vergnenègre A, Pugnere N, Antonini MT, Arnaud M, Melloni B, Treves R and Bonnaud F: Airway obstruction and rheumatoid arthritis. Eur Respir J. 10:1072–1078. 1997. View Article : Google Scholar : PubMed/NCBI | |
|
Bilgici A, Ulusoy H, Kuru O, Celenk C, Unsal M and Danacı M: Pulmonary involvement in rheumatoid arthritis. Rheumatol Int. 25:429–435. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Natalini JG, Swigris JJ, Morisset J, Elicker BM, Jones KD, Fischer A, Collard HR and Lee JS: Understanding the determinants of health-related quality of life in rheumatoid arthritis-associated interstitial lung disease. Respir Med. 127:1–6. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Singh N, Varghese J, England BR, Solomon JJ, Michaud K, Mikuls TR, Healy HS, Kimpston EM and Schweizer ML: Impact of the pattern of interstitial lung disease on mortality in rheumatoid arthritis: A systematic literature review and meta-analysis. Semin Arthritis Rheum. 49:358–365. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Shaw M, Collins BF, Ho LA and Raghu G: Rheumatoid arthritis-associated lung disease. Eur Respir Rev. 24:1–16. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Aslam B, Basit M, Nisar MA, Khurshid M and Rasool MH: Proteomics: Technologies and their applications. J Chromatogr Sci. 55:182–196. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Yasuda T, Tahara K and Sawada T: Detection of salivary citrullinated cytokeratin 13 in healthy individuals and patients with rheumatoid arthritis by proteomics analysis. PLoS One. 17:e02656872022. View Article : Google Scholar : PubMed/NCBI | |
|
Liu S, Ji W, Lu J, Tang X, Guo Y, Ji M, Xu T, Gu W, Kong D, Shen Q, et al: Discovery of potential serum protein biomarkers in ankylosing spondylitis using tandem mass tag-based quantitative proteomics. J Proteome Res. 19:864–872. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Zhou G, Wei P, Lan J, He Q, Guo F, Guo Y, Gu W, Xu T and Liu S: TMT-based quantitative proteomics analysis and potential serum protein biomarkers for systemic lupus erythematosus. Clin Chim Acta. 534:43–49. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Wu X, Jeong Y, Poli de Frías S, Easthausen I, Hoffman K, Oromendia C, Taheri S, Esposito AJ, Quesada Arias L, Ayaub EA, et al: Serum proteomic profiling of rheumatoid arthritis-interstitial lung disease with a comparison to idiopathic pulmonary fibrosis. Thorax. 77:1041–1044. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Song LN, Kong XD, Wang HJ and Zhan LB: Establishment of a rat adjuvant arthritis-interstitial lung disease model. Biomed Res Int. 2016:29707832016. View Article : Google Scholar : PubMed/NCBI | |
|
National Institutes of Health (U.S.), . Office for Protection from Research Risks: Public Health Service policy on humane care and use of laboratory animals. Office for Protection from Research Risks (OPRR). National Institutes of Health; 1986, PubMed/NCBI | |
|
An ZP: BS: Lung function test in wistar rats. Chin J Lab Anim Sci. 12:102–104. 2013. | |
|
Wei X, Zhou R, Chen Y, Ma G, Yang Y, Lu C, Xu W and Hu W: Systemic pharmacological verification of Baixianfeng decoction regulating TNF-PI3K-Akt-NF-κB pathway in treating rheumatoid arthritis. Bioorg Chem. 119:1055192022. View Article : Google Scholar : PubMed/NCBI | |
|
Goldner J: A modification of the masson trichrome technique for routine laboratory purposes. Am J Pathol. 14:237–243. 1938.PubMed/NCBI | |
|
Szapiel SV, Elson NA, Fulmer JD, Hunninghake GW and Crystal RG: Bleomycin-induced interstitial pulmonary disease in the nude, athymic mouse. Am Rev Respir Dis. 120:893–899. 1979.PubMed/NCBI | |
|
Wiśniewski JR, Zougman A, Nagaraj N and Mann M: Universal sample preparation method for proteome analysis. Nat Methods. 6:359–362. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Chen C, Chen H, Zhang Y, Thomas HR, Frank MH, He Y and Xia R: TBtools: An integrative toolkit developed for interactive analyses of big biological data. Mol Plant. 13:1194–1202. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Figus FA, Piga M, Azzolin I, McConnell R and Iagnocco A: Rheumatoid arthritis: Extra-articular manifestations and comorbidities. Autoimmun Rev. 20:1027762021. View Article : Google Scholar : PubMed/NCBI | |
|
Schurgers E, Mertens F, Vanoirbeek JA, Put S, Mitera T, De Langhe E, Billiau A, Hoet PH, Nemery B, Verbeken E and Matthys P: Pulmonary inflammation in mice with collagen-induced arthritis is conditioned by complete Freund's adjuvant and regulated by endogenous IFN-γ. Eur J Immunol. 42:3223–3234. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Lei W and Jian L: Changes of CD4(+) CD25(+) regulatory T cells, FoxP3 in adjuvant arthritis rats with damage of pulmonary function and effects of tripterygium glycosides tablet. Int J Rheumatol. 2012:3484502012. View Article : Google Scholar : PubMed/NCBI | |
|
Lucas R, Czikora I, Sridhar S, Zemskov EA, Oseghale A, Circo S, Cederbaum SD, Chakraborty T, Fulton DJ, Caldwell RW and Romero MJ: Arginase 1: An unexpected mediator of pulmonary capillary barrier dysfunction in models of acute lung injury. Front Immunol. 4:2282013. View Article : Google Scholar : PubMed/NCBI | |
|
Kim JT, Li C, Weiss HL, Zhou Y, Liu C, Wang Q and Evers BM: Regulation of ketogenic enzyme HMGCS2 by Wnt/β-catenin/PPARγ pathway in intestinal cells. Cells. 8:11062019. View Article : Google Scholar : PubMed/NCBI | |
|
Su SG, Yang M, Zhang MF, Peng QZ, Li MY, Liu LP and Bao SY: miR-107-mediated decrease of HMGCS2 indicates poor outcomes and promotes cell migration in hepatocellular carcinoma. Int J Biochem Cell Biol. 91:53–59. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Elorza A, Soro-Arnáiz I, Meléndez-Rodríguez F, Rodríguez-Vaello V, Marsboom G, de Cárcer G, Acosta-Iborra B, Albacete-Albacete L, Ordóñez A, Serrano-Oviedo L, et al: HIF2α acts as an mTORC1 activator through the amino acid carrier SLC7A5. Mol Cell. 48:681–691. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Sokolov AM, Holmberg JC and Feliciano DM: The amino acid transporter Slc7a5 regulates the mTOR pathway and is required for granule cell development. Hum Mol Genet. 29:3003–3013. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Nojima Y, Takeda Y, Maeda Y, Bamba T, Fukusaki E, Itoh MN, Mizuguchi K and Kumanogoh A: Metabolomic analysis of fibrotic mice combined with public RNA-Seq human lung data reveal potential diagnostic biomarker candidates for lung fibrosis. FEBS Open Bio. 10:2427–2436. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Ehrnthaller C, Ignatius A, Gebhard F and Huber-Lang M: New insights of an old defense system: Structure, function, and clinical relevance of the complement system. Mol Med. 17:317–329. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Dunkelberger JR and Song WC: Complement and its role in innate and adaptive immune responses. Cell Res. 20:34–50. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Hanna J, Ah-Pine F, Boina C, Bedoui Y, Gasque P and Septembre-Malaterre A: Deciphering the role of the anaphylatoxin C3a: A key function in modulating the tumor microenvironment. Cancers (Basel). 15:29862023. View Article : Google Scholar : PubMed/NCBI | |
|
Monk PN, Scola AM, Madala P and Fairlie DP: Function, structure and therapeutic potential of complement C5a receptors. Br J Pharmacol. 152:429–448. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Guo Z, Fan X, Yao J, Tomlinson S, Yuan G and He S: The role of complement in nonalcoholic fatty liver disease. Front Immunol. 13:10174672022. View Article : Google Scholar : PubMed/NCBI | |
|
Triggianese P, Conigliaro P, De Martino E, Monosi B and Chimenti MS: Overview on the link between the complement system and auto-immune articular and pulmonary disease. Open Access Rheumatol. 15:65–79. 2023. View Article : Google Scholar : PubMed/NCBI | |
|
Luo R, Wang T, Zhuo S, Guo X and Ma D: Excessive hydrogen sulfide causes lung and brain tissue damage by promoting PARP1/Bax and C9 and inhibiting LAMB1. Apoptosis. 27:149–160. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Pellicano C, Miglionico M, Romaggioli L, Colalillo A, Vantaggio L, Napodano C, Callà C, Gulli F, Marino M, Basile U and Rosato E: Increased Complement activation in systemic sclerosis patients with skin and lung fibrosis. J Pers Med. 12:2842022. View Article : Google Scholar : PubMed/NCBI | |
|
Ogawa T, Shichino S, Ueha S, Ogawa S and Matsushima K: Complement protein C1q activates lung fibroblasts and exacerbates silica-induced pulmonary fibrosis in mice. Biochem Biophys Res Commun. 603:88–93. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Duerr J, Leitz DHW, Szczygiel M, Dvornikov D, Fraumann SG, Kreutz C, Zadora PK, Seyhan Agircan A, Konietzke P, Engelmann TA, et al: Conditional deletion of Nedd4-2 in lung epithelial cells causes progressive pulmonary fibrosis in adult mice. Nat Commun. 11:20122020. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang Y, Lv X, Chen L and Liu Y: The role and function of CLU in cancer biology and therapy. Clin Exp Med. Sep 13–2022.(Epub ahead of print). View Article : Google Scholar | |
|
Ishikawa Y, Ishii T, Akasaka Y, Masuda T, Strong JP, Zieske AW, Takei H, Malcom GT, Taniyama M, Choi-Miura NH and Tomita M: Immunolocalization of apolipoproteins in aortic atherosclerosis in American youths and young adults: Findings from the PDAY study. Atherosclerosis. 158:215–225. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Hong JY, Kim MN, Kim EG, Lee JW, Kim HR, Kim SY, Lee SM, Kim YH, Kim KW and Sohn MH: Clusterin deficiency exacerbates hyperoxia-induced acute lung injury. Cells. 10:9442021. View Article : Google Scholar : PubMed/NCBI | |
|
Fox CR and Parks GD: Complement inhibitors vitronectin and clusterin are recruited from human serum to the surface of coronavirus OC43-infected lung cells through antibody-dependent mechanisms. Viruses. 14:292021. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang Q, Yue Y and Zheng R: Clusterin as a serum biomarker candidate contributes to the lung fibroblasts activation in chronic obstructive pulmonary disease. Chin Med J (Engl). 135:1076–1086. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Blom AM, Kask L and Dahlbäck B: Structural requirements for the complement regulatory activities of C4BP. J Biol Chem. 276:27136–27144. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Ermert D and Blom AM: C4b-binding protein: The good, the bad and the deadly. Novel functions of an old friend. Immunol Lett. 169:82–92. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Khadzhieva M, Kuzovlev AN and Salnikova LE: Pneumonia: Host susceptibility and shared genetics with pulmonary function and other traits. Clin Exp Immunol. 198:367–380. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Dasari P, Koleci N, Shopova IA, Wartenberg D, Beyersdorf N, Dietrich S, Sahagún-Ruiz A, Figge MT, Skerka C, Brakhage AA and Zipfel PF: Enolase from Aspergillus fumigatus is a moonlighting protein that binds the human plasma complement proteins factor H, FHL-1, C4BP, and plasminogen. Front Immunol. 10:25732019. View Article : Google Scholar : PubMed/NCBI | |
|
Kulkarni HS, Liszewski MK, Brody SL and Atkinson JP: The complement system in the airway epithelium: An overlooked host defense mechanism and therapeutic target? J Allergy Clin Immunol. 141:1582–1586. e12018. View Article : Google Scholar : PubMed/NCBI | |
|
Kyung Lee M, Armstrong DA, Hazlett HF, Dessaint JA, Mellinger DL, Aridgides DS, Christensen BC and Ashare A: Exposure to extracellular vesicles from Pseudomonas aeruginosa result in loss of DNA methylation at enhancer and DNase hypersensitive site regions in lung macrophages. Epigenetics. 16:1187–1200. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Armstrong DA, Lee MK, Hazlett HF, Dessaint JA, Mellinger DL, Aridgides DS, Hendricks GM, Abdalla MAK, Christensen BC and Ashare A: Extracellular vesicles from Pseudomonas aeruginosa suppress MHC-related molecules in human lung macrophages. Immunohorizons. 4:508–519. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Gaurav R, Mikuls TR, Thiele GM, Nelson AJ, Niu M, Guda C, Eudy JD, Barry AE, Wyatt TA, Romberger DJ, et al: High-throughput analysis of lung immune cells in a combined murine model of agriculture dust-triggered airway inflammation with rheumatoid arthritis. PLoS One. 16:e02407072021. View Article : Google Scholar : PubMed/NCBI | |
|
Ricklin D, Hajishengallis G, Yang K and Lambris JD: Complement: A key system for immune surveillance and homeostasis. Nat Immunol. 11:785–797. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Lener M, Vinci G, Duponchel C, Meo T and Tosi M: Molecular cloning, gene structure and expression profile of mouse C1 inhibitor. Eur J Biochem. 254:117–122. 1998. View Article : Google Scholar : PubMed/NCBI | |
|
Chaudhary N, Jayaraman A, Reinhardt C, Campbell JD and Bosmann M: A single-cell lung atlas of complement genes identifies the mesothelium and epithelium as prominent sources of extrahepatic complement proteins. Mucosal Immunol. 15:927–939. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Danobeitia JS, Ziemelis M, Ma X, Zitur LJ, Zens T, Chlebeck PJ, Van Amersfoort ES and Fernandez LA: Complement inhibition attenuates acute kidney injury after ischemia-reperfusion and limits progression to renal fibrosis in mice. PLoS One. 12:e01837012017. View Article : Google Scholar : PubMed/NCBI | |
|
Curci C, Castellano G, Stasi A, Divella C, Loverre A, Gigante M, Simone S, Cariello M, Montinaro V, Lucarelli G, et al: Endothelial-to-mesenchymal transition and renal fibrosis in ischaemia/reperfusion injury are mediated by complement anaphylatoxins and Akt pathway. Nephrol Dial Transplant. 29:799–808. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Yang Z, Nicholson SE, Cancio TS, Cancio LC and Li Y: Complement as a vital nexus of the pathobiological connectome for acute respiratory distress syndrome: An emerging therapeutic target. Front Immunol. 14:11004612023. View Article : Google Scholar : PubMed/NCBI | |
|
Kotlyarov S and Kotlyarova A: Anti-Inflammatory function of fatty acids and involvement of their metabolites in the resolution of inflammation in chronic obstructive pulmonary disease. Int J Mol Sci. 22:128032021. View Article : Google Scholar : PubMed/NCBI | |
|
Kočar E, Režen T and Rozman D: Cholesterol, lipoproteins, and COVID-19: Basic concepts and clinical applications. Biochim Biophys Acta Mol Cell Biol Lipids. 1866:1588492021. View Article : Google Scholar : PubMed/NCBI | |
|
Tanner JE and Alfieri C: The fatty acid lipid metabolism nexus in COVID-19. Viruses. 13:902021. View Article : Google Scholar : PubMed/NCBI | |
|
Hu X, Ge X, Liang W, Shao Y, Jing J, Wang C, Zeng R and Yao B: Effects of saturated palmitic acid and omega-3 polyunsaturated fatty acids on Sertoli cell apoptosis. Syst Biol Reprod Med. 64:368–380. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Chu SG, Villalba JA, Liang X, Xiong K, Tsoyi K, Ith B, Ayaub EA, Tatituri RV, Byers DE, Hsu FF, et al: Palmitic acid-rich high-fat diet exacerbates experimental pulmonary fibrosis by modulating endoplasmic reticulum stress. Am J Respir Cell Mol Biol. 61:737–746. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Jo Y, Sguigna PV and DeBose-Boyd RA: Membrane-associated ubiquitin ligase complex containing gp78 mediates sterol-accelerated degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase. J Biol Chem. 286:15022–15031. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Huang SSY, Toufiq M, Saraiva LR, Van Panhuys N, Chaussabel D and Garand M: Transcriptome and literature mining highlight the differential expression of ERLIN1 in immune cells during sepsis. Biology (Basel). 10:7552021.PubMed/NCBI | |
|
Patrick MT, Stuart PE, Zhang H, Zhao Q, Yin X, He K, Zhou XJ, Mehta NN, Voorhees JJ, Boehnke M, et al: Causal relationship and shared genetic loci between psoriasis and type 2 diabetes through trans-disease meta-analysis. J Invest Dermatol. 141:1493–1502. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Ma APY, Yeung CLS, Tey SK, Mao X, Wong SWK, Ng TH, Ko FCF, Kwong EML, Tang AHN, Ng IO, et al: Suppression of ACADM-mediated fatty acid oxidation promotes hepatocellular carcinoma via aberrant CAV1/SREBP1 signaling. Cancer Res. 81:3679–3692. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Dong Y, Lu H, Li Q, Qi X, Li Y, Zhang Z, Chen J and Ren J: (5R)-5-hydroxytriptolide ameliorates liver lipid accumulation by suppressing lipid synthesis and promoting lipid oxidation in mice. Life Sci. 232:1166442019. View Article : Google Scholar : PubMed/NCBI | |
|
Xu Y, Denning KL and Lu Y: PPARα agonist WY-14,643 induces the PLA2/COX-2/ACOX1 pathway to enhance peroxisomal lipid metabolism and ameliorate alcoholic fatty liver in mice. Biochem Biophys Res Commun. 613:47–52. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Kong A, Xu D, Hao T, Liu Q, Zhan R, Mai K and Ai Q: Role of acyl-coenzyme A oxidase 1 (ACOX1) on palmitate-induced inflammation and ROS production of macrophages in large yellow croaker (Larimichthys crocea). Dev Comp Immunol. 136:1045012022. View Article : Google Scholar : PubMed/NCBI | |
|
Vallée A, Lecarpentier Y, Guillevin R and Vallée JN: Interactions between TGF-β1, canonical WNT/β-catenin pathway and PPAR γ in radiation-induced fibrosis. Oncotarget. 8:90579–90604. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Milam JE, Keshamouni VG, Phan SH, Hu B, Gangireddy SR, Hogaboam CM, Standiford TJ, Thannickal VJ and Reddy RC: PPAR-gamma agonists inhibit profibrotic phenotypes in human lung fibroblasts and bleomycin-induced pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol. 294:L891–L901. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Biniecka M, Canavan M, McGarry T, Gao W, McCormick J, Cregan S, Gallagher L, Smith T, Phelan JJ, Ryan J, et al: Dysregulated bioenergetics: A key regulator of joint inflammation. Ann Rheum Dis. 75:2192–2200. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Ma C, Wei J, Zhan F, Wang R, Fu K, Wan X and Li Z: Urinary hypoxia-inducible factor-1alpha levels are associated with histologic chronicity changes and renal function in patients with lupus nephritis. Yonsei Med J. 53:587–592. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Manresa MC and Taylor CT: Hypoxia inducible factor (HIF) hydroxylases as regulators of intestinal epithelial barrier function. Cell Mol Gastroenterol Hepatol. 3:303–315. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Fu X and Zhang F: Role of the HIF-1 signaling pathway in chronic obstructive pulmonary disease. Exp Ther Med. 16:4553–4561. 2018.PubMed/NCBI | |
|
Yu H, Li Q, Kolosov VP, Perelman JM and Zhou X: Regulation of cigarette smoke-mediated mucin expression by hypoxia-inducible factor-1α via epidermal growth factor receptor-mediated signaling pathways. J Appl Toxicol. 32:282–292. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Tzouvelekis A, Harokopos V, Paparountas T, Oikonomou N, Chatziioannou A, Vilaras G, Tsiambas E, Karameris A, Bouros D and Aidinis V: Comparative expression profiling in pulmonary fibrosis suggests a role of hypoxia-inducible factor-1alpha in disease pathogenesis. Am J Respir Crit Care Med. 176:1108–1119. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Bryant AJ, Carrick RP, McConaha ME, Jones BR, Shay SD, Moore CS, Blackwell TR, Gladson S, Penner NL, Burman A, et al: Endothelial HIF signaling regulates pulmonary fibrosis-associated pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol. 310:L249–L262. 2016. View Article : Google Scholar : PubMed/NCBI |
